We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

266 hedge funds and large institutions have $4.24B invested in Immunogen Inc in 2023 Q2 according to their latest regulatory filings, with 101 funds opening new positions, 67 increasing their positions, 72 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

426% more capital invested

Capital invested by funds: $805M → $4.24B (+$3.43B)

304% more first-time investments, than exits

New positions opened: 101 | Existing positions closed: 25

93% more call options, than puts

Call options by funds: $69.3M | Put options by funds: $35.8M

40% more funds holding

Funds holding: 190 → 266 (+76)

7% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 72

Holders
266
Holders Change
+76
Holders Change %
+40%
% of All Funds
4.18%
Holding in Top 10
13
Holding in Top 10 Change
+13
Holding in Top 10 Change %
% of All Funds
0.2%
New
101
Increased
67
Reduced
72
Closed
25
Calls
$69.3M
Puts
$35.8M
Net Calls
+$33.4M
Net Calls Change
+$21.4M

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$114M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$103M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$74.2M
4
FFM
Fairmount Funds Management
Pennsylvania
+$71.2M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$70M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$231M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$201M
3
State Street
State Street
Massachusetts
-$108M
4
MC
Maverick Capital
Texas
-$48M
5
Morgan Stanley
Morgan Stanley
New York
-$47M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$394M +$34.3M +2,908,657 +16%
Vanguard Group
2
Vanguard Group
Pennsylvania
$394M +$70M +5,930,704 +40%
RG
3
Redmile Group
California
$335M +$114M +9,684,200 +120%
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$292M -$11.2M -950,293 -6%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$184M -$1.32M -111,886 -1%
Point72 Asset Management
6
Point72 Asset Management
Connecticut
$164M +$103M +8,712,142 New
State Street
7
State Street
Massachusetts
$150M -$108M -9,138,044 -54%
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$119M +$74.2M +6,280,516 New
FFM
9
Fairmount Funds Management
Pennsylvania
$114M +$71.2M +6,029,592 New
Fidelity Investments
10
Fidelity Investments
Massachusetts
$106M +$52.1M +4,413,468 +368%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$89.7M +$8.42M +713,154 +18%
MC
12
Maverick Capital
Texas
$71.5M -$48M -4,069,511 -52%
Artisan Partners
13
Artisan Partners
Wisconsin
$70.3M +$6.43M +544,542 +17%
Morgan Stanley
14
Morgan Stanley
New York
$63M -$47M -3,981,093 -54%
Deutsche Bank
15
Deutsche Bank
Germany
$62.4M +$2.68M +226,883 +7%
HRCM
16
Hood River Capital Management
Florida
$56.3M +$35.2M +2,983,671 New
BC
17
Boxer Capital
California
$55.9M +$35M +2,961,000 New
Millennium Management
18
Millennium Management
New York
$50.9M -$3.29M -279,061 -9%
N
19
Nuveen
North Carolina
$49.9M -$6.51M -550,980 -17%
WP
20
Woodline Partners
California
$48.1M +$30.1M +2,547,639 New
Northern Trust
21
Northern Trust
Illinois
$45.2M +$2.98M +252,225 +12%
RCM
22
RA Capital Management
Massachusetts
$44M -$231M -19,524,000 -89%
T. Rowe Price Associates
23
T. Rowe Price Associates
Maryland
$43.8M +$26.1M +2,208,333 +1,938%
Voloridge Investment Management
24
Voloridge Investment Management
Florida
$38.3M +$24M +2,030,955 New
APM
25
Avidity Partners Management
Texas
$37.7M +$23.6M +1,997,800 New
1
2 3 4 5

IMGN Hedge Fund Activity: Q2 2023 in Review

266 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2023, worth a combined $4.24B — up 426% from $805M a quarter earlier.

Buyers outnumbered sellers: 101 funds opened new IMGN positions and 25 closed out — a net gain of 76 holders — while 67 added to existing stakes and 72 trimmed.

The largest buyer was Redmile Group, adding an estimated $114M. The largest seller was RA Capital Management, cutting an estimated $231M.

  • 266 institutional investors held Immunogen Inc (IMGN) as of Q2 2023, up from 190 in Q1 2023.
  • Funds reported $4.24B of Immunogen Inc stock for Q2 2023, up 426% quarter-over-quarter.
  • 101 funds opened new Immunogen Inc positions in Q2 2023 and 25 closed out, a net change of +76 holders.
  • The largest Immunogen Inc buyer in Q2 2023 was Redmile Group, an estimated $114M added.
  • The largest Immunogen Inc seller in Q2 2023 was RA Capital Management, an estimated $231M sold.

Based on aggregated 13F filings for Q2 2023.